NEAUVIA

Founded in 2012, Neauvia is distributed in more than 80 countries worldwide. It is now a fast-growing multinational with production sites and subsidiaries in Italy, Switzerland, France, Spain, Poland, Germany, the United Kingdom, and the United States.

Neauvia offers clinically proven combined solutions for healthcare professionals and patients.
As part of the MatexLab group, which is supported by the private equity firm Abris Capital, a leader in Central Europe, Neauvia is a pioneer in medical aesthetics and has developed revolutionary smart synergistic therapies.